Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIBS: Mebeverine, Methylcellulose, and CBT for IBS
NCT00934973Phase 4Completed
- Start
- Apr 2010
- Primary completion
- Sep 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mebeverine, methylcellulose in irritable bowel syndrome (IBS). Started Apr 2010; status: completed.
02
Drugs
mebeverinemethylcellulose
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00934973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934973.